LAB vs QCOM · rev $174.4M vs P/E 16, rev $44.28B
Standard Biotools Inc (LAB) versus Qualcomm Incorporated (QCOM) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Qualcomm Incorporated (QCOM) is a semiconductors company listed on US. It is led by Cristiano Amon.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported QCOM revenue for 2025-09-28 was $44.28B. Net income was $5.54B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
LAB currently screens at market cap $317.1M. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
Not investment advice. Open the LAB and QCOM stock pages for the full models.
Not investment advice.